Riboswitches are mRNA-based modules that control gene expression through direct RNA-ligand interactions.[1) In most cases, the regulatory ligands are metabolites that act on their own biosynthesis genes through feedback regulation. Since their discovery by Breaker and co-workers in 2002, nucleobases, amino acids, cofactors, as well as the amino sugar glucosamine-6-phosphate have been described to trigger changes in gene expression by binding to riboswitches.(1) It became apparent that such protein-free regulation mechanisms are frequently found in bacteria with some examples such as thiamine pyrophosphate-dependent switches that even operate in plants and fungi. Riboswitches mostly operate through a common mechanism: ligand binding to an aptamer domain triggers a rearrangement in the 5'-untranslated region of an mRNA at which bacterial riboswitches usually are located. This event results in a structural rearrangement of the so-called expression platform, and provokes changes in transcription termination or initiation of translation. A different mechanism has been described in case of the glms-riboswitch in which glucosamine-6-phosphate acts as a cofactor and triggers scission of the respective mRNA through the action of a phosphodiestercleaving ribozyme.
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The described riboswitches are typical examples of in cisacting regulatory mechanisms; this means that the riboswitch exclusively controls the expression of the riboswitch-containing mRNA. On the other hand, several examples of in transacting small regulatory RNAs (so-called sRNAs) have been described in bacteria. [2) A subclass of sRNAs acts in trans through base-pairing to mRNAs that contain complementary sequences. In a recent report (ossart, Johansson and co-workers described for the first time that riboswitches formerly identified to be regulated by the cofactor S-adenosylmethionine (SAM) [3) also act on other mRNAs in the pathogen Listeria monocytogenes.l [S) Among them, SAM-dependent riboswitches are found in mRNAs that code for methionine and cysteine metabolism and uptake. They act by terminating transcription upon SAM binding, see Figure 1 A. Surprisingly, two of these SAM riboswitches (SreA and SreB) were found to influence the expression of several other genes. The influence on one of these genes, the virulence factor PrfA, was studied in more detail and found to be inhibited in trans, presumably through an an- Hence it is still unclear whether the intracellular SAM concentration affects PrfA expression because the full-length RNA containing the Sre elements could as well act in trans in a SAM-independent manner. In the latter case, the two distinct regulatory functions would just (coincidentally?) be harboured by the same piece of RNA. Nevertheless, the example shows how nature makes use of very economic but sophisticated RNA-based mechanisms to implement complex regulatory functions. Along this line, the discovery of combinations of two regulatory elements in one message should be mentioned. For example, the Baeillus cJausii metE mRNA contains both riboswitches for SAM as well as for coenzyme B 12 ; these riboswitches act in concert as a Boolean NOR gate.[6J The discovery of complex RNA-based regulators in nature also has implications for the construction of artificial RNA-based switches. In recent years, several man-made RNA regulators have been described in the Iiteraturep,8J So far, only eis-acting systems have been constructed in bacteria. The likelihood that trans-acting ligand-dependent RNA regulators occur in nature provides the opportunity to hard-wire synthetic RNA switches to have more than one output, and hence implement more complex behaviours by utilizing minimal information processing units made up from RNA. In order to realize such RNA synthetic biology tasks, further studies of the present as well as additional examples likely to exist in nature will be of great value.
